What Is Neuroprosthetics? Rebuilding Function Through Technology

700,000 People Can Hear Right Now Because of a Wire in Their Skull

There's a video that gets passed around neuroscience departments like a sacred text. A woman in her late twenties sits in a doctor's office. An audiologist flips a switch. And for the first time in the woman's entire life, she hears sound.

She sobs. Her hands fly to her mouth. She looks at her mother and hears her mother's voice. She's heard nothing, not a whisper, not a car horn, not a thunderclap, for almost three decades. And then a small device implanted in her inner ear starts converting sound waves into electrical pulses, delivers those pulses to her auditory nerve, and her brain does what it has always been wired to do. It listens.

That device is a cochlear implant. It's the most successful neuroprosthetic ever built. And most people don't even realize it's a neuroprosthetic at all.

The word "neuroprosthetics" sounds like it belongs in a sci-fi film, filed somewhere between "cyborg" and "bionic." But the field is older, more practical, and more profoundly life-changing than most people know. It's not about turning humans into machines. It's about something much simpler and much more important: when the nervous system breaks, neuroprosthetics fill the gap.

The One Sentence That Defines the Entire Field

Here it is: a neuroprosthetic is any device that interfaces directly with the nervous system to replace or restore a function that biology can no longer perform.

That's it. That's the whole definition. But the range of what fits inside that sentence is staggering.

A cochlear implant that converts sound into nerve stimulation? Neuroprosthetic. A retinal chip that sends light patterns directly to damaged eyes? Neuroprosthetic. A deep brain stimulator that quiets the tremors of Parkinson's disease? Neuroprosthetic. A brain-computer interface that lets a paralyzed person control a robotic arm with thought alone? Also neuroprosthetic.

The common thread is the interface. Every neuroprosthetic device has to solve the same fundamental engineering problem: how do you speak the language of the nervous system? Neurons communicate in electrical pulses. They fire in patterns, at specific frequencies, with precise timing. To replace a lost function, you need to either read those patterns (to decode what the brain wants to do) or generate them (to feed the brain information it's no longer receiving). Often both.

This is why neuroprosthetics sits at such a fascinating crossroads. You need neuroscience to understand which signals matter. You need electrical engineering to build hardware that can detect or produce signals at the microvolt scale. You need materials science to create devices the body won't reject. You need machine learning to decode the brain's intentions from noisy data. And you need medicine to put it all together inside a living person without causing harm.

No single discipline owns this field. It belongs to all of them.

The Major Types: A Field Guide to Rebuilding the Nervous System

Neuroprosthetics aren't one technology. They're a family of technologies, each designed for a different part of the nervous system and a different type of lost function. Here's how they break down.

Let's take a closer look at each one.

Cochlear Implants: The Neuroprosthetic You Forgot Was a Neuroprosthetic

The cochlear implant is the quiet giant of the field. It's been around since the 1970s. Over 700,000 people worldwide have one. Insurance covers it. Children receive them before their first birthday. It's so successful, so normalized, that people stopped thinking of it as a marvel of neural engineering.

But it absolutely is.

Here's the problem it solves. In sensorineural hearing loss, the tiny hair cells inside the cochlea, the snail-shaped organ in your inner ear, are damaged or destroyed. These hair cells are supposed to convert sound vibrations into electrical signals for the auditory nerve. When they die, the conversion stops. Sound waves still reach the ear, but there's nothing left to translate them into the language of the brain.

A cochlear implant replaces those hair cells with technology. An external microphone captures sound. A speech processor, worn behind the ear, analyzes the incoming audio and breaks it into frequency bands. A transmitter sends that processed information wirelessly across the skin to a receiver implanted in the skull. And an electrode array threaded into the cochlea delivers tiny electrical currents at specific positions along its length.

Here's the clever part. The cochlea is tonotopically organized, meaning different positions along its spiral correspond to different sound frequencies. High-pitched sounds are processed near the base, low-pitched sounds near the tip. The electrode array exploits this natural mapping. It delivers high-frequency signals to electrodes near the base and low-frequency signals to electrodes near the tip, mimicking the frequency-to-position code that healthy hair cells use.

The auditory nerve receives these electrical patterns and carries them to the brain, just as it would carry signals from biological hair cells. The brain, remarkably, learns to interpret them as sound. Not perfectly, not instantly (adaptation takes weeks to months), but well enough that most cochlear implant users can understand speech, talk on the phone, and enjoy music.

This is the template for all neuroprosthetics: understand the neural code, build hardware that speaks it, and trust the brain's plasticity to close whatever gap remains between artificial and natural.

Retinal Prostheses: Feeding Light Directly to the Eye

If the cochlear implant is neuroprosthetics' greatest success story, the retinal prosthesis is its most tantalizing unfinished chapter.

The concept is similar. In conditions like retinitis pigmentosa, the photoreceptor cells in the retina (rods and cones) die off progressively, leaving the person blind. But the retinal ganglion cells, the neurons that would normally carry visual information from the photoreceptors to the brain via the optic nerve, often survive. So the idea is straightforward: bypass the dead photoreceptors, stimulate the ganglion cells directly, and let the brain see again.

The Argus II, developed by Second Sight, was the most widely known retinal prosthesis. It used a camera mounted on a pair of glasses, a processing unit worn on a belt, and a 60-electrode array implanted on the surface of the retina. The camera captured an image, the processor converted it into a pattern of electrical stimulation, and the electrode array delivered that pattern to the retinal ganglion cells.

The result was not normal vision. Sixty electrodes means roughly 60 pixels. Try to imagine seeing the world through a grid of 60 dots of light on a dark background. You can't read. You can't recognize faces. But you can detect doorways, follow a sidewalk, locate large objects, and navigate a room. For someone who has been completely blind, those capabilities are not trivial.

The field is now pushing in two directions. One is better retinal implants with higher electrode counts, potentially reaching into the hundreds or thousands. The other, more radical approach is to bypass the eye entirely and stimulate the visual cortex directly. Cortical visual prostheses implant electrode arrays on the brain's primary visual cortex, creating phosphenes (points of light) that can be arranged into patterns representing the visual scene. Early human trials by researchers at Baylor College of Medicine and by the company Cortica have shown that cortical stimulation can produce recognizable shapes and letters.

The visual cortex approach has a massive theoretical advantage. It works regardless of the condition of the eye or the optic nerve. Any form of blindness caused by anything upstream of the visual cortex, including damage to both eyes, the optic nerves, or the retina, could potentially be addressed. But the engineering challenges are enormous. The visual cortex processes information with far more complexity than the tonotopic frequency map of the cochlea, and achieving even moderate resolution requires hundreds of precisely placed electrodes in cortical tissue.

Deep Brain Stimulation: The Pacemaker for Your Brain

If you've ever heard someone with Parkinson's disease describe what deep brain stimulation (DBS) did for them, you've heard a story that sounds almost impossible.

One moment, their hands shake so badly they can't lift a spoon to their mouth. A surgeon threads a thin electrode deep into a specific brain nucleus, the subthalamic nucleus or the globus pallidus internus. The electrode connects to a pulse generator implanted under the collarbone, essentially a pacemaker for the brain. The generator is switched on. And the tremor stops. Sometimes within seconds.

There are videos of this. They look like miracles. A person with severe tremor draws a spiral on paper. It's an illegible zigzag. The stimulator is activated. They draw another spiral. It's smooth. The difference is so dramatic it's hard to believe you're looking at the same person, the same hand, seconds apart.

DBS works by delivering continuous, high-frequency electrical pulses (typically 130-185 Hz) to the target nucleus. The exact mechanism is still debated by neuroscientists, which is a refreshingly honest thing to admit about a technology used by over 200,000 people. The leading theory is that the stimulation overrides abnormal neural oscillations in the basal ganglia circuit. In Parkinson's disease, dopamine loss causes neurons in the subthalamic nucleus to fire in pathological beta-frequency rhythms (around 13-30 Hz) that propagate through the motor circuit and produce tremor and rigidity. DBS disrupts these rhythms, essentially jamming the bad signal so the motor cortex can function normally.

Here's the "I had no idea" moment about DBS. The latest generation of devices are adaptive. Traditional DBS delivers the same continuous stimulation regardless of what the brain is doing. But newer systems, called closed-loop or adaptive DBS, include sensing electrodes that read the brain's electrical activity in real-time. When the pathological beta oscillations surge, the stimulator ramps up. When they subside, stimulation decreases. The device listens to the brain and adjusts its output based on what it hears.

This is the exact same principle behind neurofeedback: read the brain's state, respond to it, and close the loop. The difference is that DBS operates on deep brain structures through implanted electrodes, while neurofeedback operates on surface-level brainwaves through external sensors. But the logic is identical. And the engineering insights flow in both directions.

Motor Neuroprosthetics: When the Brain Drives the Machine

This is where neuroprosthetics and brain-computer interfaces merge most directly. Motor neuroprosthetics aim to restore voluntary movement to people who've lost it, whether from spinal cord injury, stroke, or neurodegenerative diseases like ALS.

The core insight is one that surprises many people. When someone is paralyzed, the brain region responsible for movement, the motor cortex, doesn't stop working. It keeps generating the same neural firing patterns it always did. The person thinks "reach for the cup" and the motor cortex obliges, firing a precise sequence of commands that would produce a reach if the spinal cord could relay them. But the pathway is broken, so the commands go nowhere.

Motor neuroprosthetics intercept those commands at the source.

The most advanced approach uses microelectrode arrays, tiny chips with up to 96 or more needle-thin electrodes, implanted directly in the motor cortex. Each electrode picks up the activity of individual neurons or small clusters of neurons. Machine learning algorithms decode the patterns of neural firing into intended movements: direction, speed, grip force. Those decoded intentions drive a robotic arm, a cursor, or even the person's own muscles through functional electrical stimulation.

The results have been extraordinary. In 2012, a woman paralyzed for 15 years grasped a bottle of coffee with a robotic arm controlled by her thoughts. In 2021, a Stanford team decoded imagined handwriting from a paralyzed man's motor cortex at 90 characters per minute, roughly smartphone typing speed. By 2025, companies like Neuralink and Synchron were conducting human trials with wireless implants, moving toward systems that could work outside the lab.

The Crown captures brainwave data at 256Hz across 8 channels. All processing happens on-device. Build with JavaScript or Python SDKs.

Explore the Crown

Non-invasive motor neuroprosthetics take a different path. Rather than implanting electrodes, they use EEG to read brain activity through the scalp. The resolution is lower (you're reading millions of neurons at once rather than individual cells), but the approach requires zero surgery and zero risk. motor imagery, the act of imagining a movement without executing it, produces detectable changes in the EEG signal over the motor cortex. A BCI can learn to classify these patterns and translate them into commands.

The speed and precision don't match invasive systems. You won't control individual fingers through EEG. But you can select between broad intentions (left vs. right, go vs. stop, yes vs. no), which is enough to drive a wheelchair, operate a spelling interface, or control a computer. And the technology is available right now, not in a clinical trial but as consumer devices with open development platforms.

How BCI Research Feeds Neuroprosthetics (and Vice Versa)

There's a pattern in the history of neuroprosthetics that's easy to miss if you're looking at each device in isolation. The research insights flow between clinical and consumer applications like water through connected vessels. An advance in one domain raises the level everywhere.

Consider signal processing. The algorithms that clean noise out of EEG data for consumer focus-tracking applications are direct descendants of the artifact rejection methods developed for clinical EEG and neuroprosthetic research. The machine learning architectures that classify motor imagery in consumer BCIs come from the same laboratories that decode intended movement for paralysis patients. The electrode materials engineered for long-term brain implants inform the design of dry electrodes used in consumer headsets.

The arrow points the other way too. Consumer BCI platforms generate vast amounts of real-world EEG data from thousands of users, in natural environments, under real conditions. This data diversity is something clinical labs can't easily replicate. It reveals how brain signals behave outside controlled settings, what artifacts look like in a living room versus a shielded laboratory, how signal quality varies across different heads and hair types. These practical insights feed back into clinical neuroprosthetic design.

The Neurosity Crown sits squarely in this feedback loop. Its 8-channel EEG system covers the same motor, frontal, and parietal regions that clinical neuroprosthetic researchers target. Its open SDKs let developers build and test neural decoding algorithms. Its on-device processing pipeline handles the same signal acquisition, filtering, and feature extraction steps that power clinical systems. The scale is different. The application is different. But the science is the same.

This is what it means for consumer BCIs and clinical neuroprosthetics to exist on the same continuum. Every developer who builds a motor imagery classifier on a consumer EEG platform is contributing to the same pool of knowledge that will eventually make neuroprosthetics faster, cheaper, and more reliable for patients who need them most.

What's Coming: The Next Ten Years of Neuroprosthetics

The trajectory of neuroprosthetics points toward several developments that are already taking shape.

Bidirectional interfaces. Most current neuroprosthetics are one-way. They either read from the nervous system or write to it. The next generation will do both simultaneously. A robotic arm controlled by motor cortex signals will also feed touch and pressure information back to the somatosensory cortex. A cochlear implant will adjust its processing based on the brain's auditory attention signals. This two-way communication will make neuroprosthetics feel dramatically more natural.

Closed-loop everything. Adaptive DBS is the template. Every type of neuroprosthetic will eventually incorporate real-time sensing and adjustment. Instead of delivering a fixed program of stimulation, future devices will continuously monitor the brain's state and modulate their output accordingly. This is neurofeedback at the hardware level.

Softer, longer-lasting materials. One of the biggest challenges for implanted neuroprosthetics is the immune response. The brain recognizes rigid silicon and metal as foreign bodies and encapsulates them in scar tissue, degrading the signal over time. New approaches using flexible polymer electrodes, carbon fiber threads, and hydrogel coatings aim to create interfaces the brain tolerates indefinitely.

The non-invasive leap. Every advance in non-invasive brain sensing, better dry electrodes, higher channel counts, faster on-device processing, moves the capabilities of consumer BCIs closer to what currently requires surgery. We're not close to matching the resolution of implanted arrays through the skull. But we don't need to match it for many useful applications. The practical capabilities of non-invasive BCIs will keep expanding as the hardware, signal processing, and machine learning improve together.

The Real Meaning of "Rebuilding Function"

There's a temptation, when writing about neuroprosthetics, to focus on the technology. The electrode counts. The decoding accuracy. The bandwidth and latency specifications.

But the technology is not the point. The point is a woman hearing her mother's voice for the first time. A man with Parkinson's drawing a smooth spiral after years of tremor. A person who hasn't moved in a decade picking up a cup of coffee with a robotic arm driven by the same thought that once moved their biological one.

Neuroprosthetics reveal something profound about the nervous system: it's modular. Function can be lost at any point along the chain, from sensory receptor to nerve to spinal cord to brain region, and a well-designed interface at the point of failure can bypass the damage and restore the chain. The brain doesn't care whether the signals coming in are from biological hardware or silicon. It cares whether the signals carry information it can use.

That modularity is also why the continuum from clinical neuroprosthetics to consumer BCIs makes sense. The same principle that lets a cochlear implant speak to the auditory nerve lets an EEG headset read the patterns of your attention. The same signal processing that decodes motor intention for a paralyzed patient decodes focus states for a developer trying to understand their own cognitive patterns. The interfaces are different. The stakes are different. But the science, the fundamental conversation between technology and nervous system, is the same conversation.

Right now, over 700,000 people hear through neuroprosthetics. Over 200,000 have steadier hands because of them. A small but growing number of paralyzed individuals are moving and communicating through them. And millions of people are beginning to explore their own brain activity through consumer BCIs that descend from the same research lineage.

The nervous system is not fragile. It's remarkably, stubbornly resilient. It just needs the right partner to fill in what's missing. Neuroprosthetics are that partner. And the field is still just getting started.